ad

Ramco Cements Q1 Results FY26: Q1 PAT Rose 128.82% to ₹85.03 Crore; Revenue Down 0.93% YoY

Q1 Results FY26


11 Aug 2025 • 10:25 pm

Ramco Cements Q1 Results FY26: Q1 PAT Rose 128.82% to ₹85.03 Crore; Revenue Down 0.93% YoY

Ramco Cements Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

ParticularsQuarter Ended
30-06-202530-06-2024
Revenue from Operations2,074.022,093.55
Profit Before Tax (PBT)403.51328.27
Profit After Tax (PAT)85.0337.16

(Figures in crores)

Ramco Cements Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

ParticularsQuarter Ended
30-06-202530-06-2024
Revenue from Operations2,070.132,088.37
Profit Before Tax (PBT)404.12327.92
Profit After Tax (PAT)86.0135.5

(Figures in crores)

Ramco Cements Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

  • Ramco Cements clocked Q1 FY26 consolidated revenue of ₹2,074.02 crores vs ₹2,093.55 crores. 
  • On the profit front, Ramco Cements earned a consolidated PAT of ₹85.03 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹37.16 crore. 
  • Consolidated PAT rose for the first quarter of FY26, was 128.82% YoY, and revenue fell 0.93% YoY. 
  • As per the standalone figures, the quarterly PAT of Ramco Cements has increased by 142.28%, and revenue has decreased by 0.87% YoY.

Ramco Cements Share Price Performance

On the opening bell of 11th August 2025, the shares of Ramco Cements opened at ₹1,051 per share. However, the initial gains are sustained as of now, and Ramco Cements shares are trading at ₹1,070.40 per share, higher than their opening price. 

Considering the long-term performance, Ramco Cements shares have yielded close to 35.32% returns in the past 1 year, and 5-year returns stand at 55.36%. Over the maximum timeframe, the Ramco Cements share provided 5,049.79% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Ramco Cements shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your research before investing in shares and other securities.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Connplex Cinemas IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down